Long-Term Safety and Efficacy of a Combination of Niacin Extended Release and Simvastatin in Patients with Dyslipidemia: The OCEANS Study

By Karas Richard H.  

American Journal of Cardiovascular Drugs, Vol. 8, Iss. 2, 2008-01 ,pp. : 69-81

Adis International

Access to resources Recommend Favorite

Niacin Extended Release (ER)/Simvastatin (Simcor®): A Guide to its Use in Lipid Regulation

By Lyseng-Williamson Katherine A.  

Drugs in R&D, Vol. 10, Iss. 4, 2010-11 ,pp. : 253-260

Adis International

Access to resources Recommend Favorite

Simultaneous Quantification of Simvastatin and Simvastatin Acid in Human Plasma with a Highly Sensitive LC-ESI-MS/MS Method: Application to a Pharmacokinetic Study in Healthy Chinese Volunteers with a Fixed Dose of Simvastatin and Extended-Release Niacin Combination Tablet

By  

Current Pharmaceutical Analysis, Vol. 12, Iss. 2, 2016-05 ,pp. : 96-106

Bentham Science Publishers

Access to resources Recommend Favorite

Niaspan: managing hyperlipidaemia with extended-release niacin

By Bradley D.  

Pharmaceutical Science & Technology Today, Vol. 3, Iss. 8, 2000-08 ,pp. : 262-263

Elsevier

Access to resources Recommend Favorite

Extended-release niacin for modifying the lipoprotein profile

By Guyton John R  

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 6, 2004-06 ,pp. : 1385-1398

Informa Healthcare

Access to resources Recommend Favorite